Literature DB >> 3396592

Long-term development of intelligence (IQ) and EEG in 34 children with phenylketonuria treated early.

J Pietz1, C Benninger, H Schmidt, D Scheffner, H Bickel.   

Abstract

In 34 children with phenylketonuria (PKU) treated early the prognostic value of the age on institution of the diet (within the first 3 months of life) and of the quality of dietary treatment was determined in two different ways: 1) following intelligence closely (IQ) and (2) evaluating the EEG development up to their 12th (n = 34) and 15th (n = 18) years of life as appropriate. In general, IQ scores were found to be normal from the 4th-15th years of life. In our group of patients there was no effect on the IQ of the timing of diet onset. Children with "strict" dietary control showed a significantly higher IQ than those with "loose" control. One hundred and fifty-four EEGs (10/20 system, awake with eyes closed) were recorded at intervals of 2 years and conventionally evaluated. The development of alpha-activity was found to be normal. Beta-activity was enhanced. Abnormal EEG findings like general slowing and generalized paroxysmal activity (GPA) with or without spikes were more frequent in children with PKU than in controls, with the exception of focal abnormalities. EEG abnormalities increased with advancing age independently of IQ development and showed no relation to either the age at the onset nor the quality of dietary treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396592     DOI: 10.1007/bf00496411

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  32 in total

1.  The influence of phenylalanine intake on the chemistry and behaviour of a phenyl-ketonuric child.

Authors:  H BICKEL; J GERRARD; E M HICKMANS
Journal:  Acta Paediatr       Date:  1954-01       Impact factor: 2.299

2.  Linguistic development of children with phenylketonuria and normal intelligence.

Authors:  C R Melnick; K K Michals; R Matalon
Journal:  J Pediatr       Date:  1981-02       Impact factor: 4.406

Review 3.  Diet termination in children with phenylketonuria: a review of psychological assessments used to determine outcome.

Authors:  S E Waisbren; R R Schnell; H L Levy
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

4.  Biochemical and EEG studies in phenylketonuric children during phenylalanine tolerance testc.

Authors:  B E Clayton; A A Moncrieff; G Pampiglione; J Shepherd
Journal:  Arch Dis Child       Date:  1966-06       Impact factor: 3.791

5.  [Growth and nutrition: long term follow-up in early treated phenylketonuric and hyperphenylalaninemic children (author's transl)].

Authors:  P Koepp; G Hinze; K R Held
Journal:  Monatsschr Kinderheilkd       Date:  1981-03       Impact factor: 0.323

6.  Correlates of intelligence test results in treated phenylketonuric children.

Authors:  M L Williamson; R Koch; C Azen; C Chang
Journal:  Pediatrics       Date:  1981-08       Impact factor: 7.124

7.  Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria.

Authors:  N A Holtzman; R A Kronmal; W van Doorninck; C Azen; R Koch
Journal:  N Engl J Med       Date:  1986-03-06       Impact factor: 91.245

8.  [E.E.G. appearances in hyperphenylalaninaemia (author's transl)].

Authors:  F Moussalli-Salefranque; J Mises; A Cheynel; M Phelippeau; J M Saudubray
Journal:  Rev Electroencephalogr Neurophysiol Clin       Date:  1978 Jan-Mar

9.  Intellectual assessment of 111 four-year-old children with phenylketonuria.

Authors:  J C Dobson; M L Williamson; C Azen; R Koch
Journal:  Pediatrics       Date:  1977-12       Impact factor: 7.124

10.  EEG in phenylketonuria. Attempt to establish clinical importance of EEG changes.

Authors:  P T Gross; S Berlow; V E Schuett; R G Fariello
Journal:  Arch Neurol       Date:  1981-02
View more
  8 in total

1.  Living with phenylketonuria: perspectives of patients and their families.

Authors:  C Bilginsoy; N Waitzman; C O Leonard; S L Ernst
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Connecting mutant phenylalanine hydroxylase with phenylketonuria.

Authors:  Shaomin Yan; Guang Wu
Journal:  J Clin Monit Comput       Date:  2008-09-05       Impact factor: 2.502

3.  Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials.

Authors:  A P Prince; M P McMurray; N R Buist
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

4.  Intelligence patterns among children with high-functioning autism, phenylketonuria, and childhood head injury.

Authors:  M Dennis; L Lockyer; A L Lazenby; R E Donnelly; M Wilkinson; W Schoonheyt
Journal:  J Autism Dev Disord       Date:  1999-02

Review 5.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

6.  Pregnancy in phenylketonuria: dietary treatment aimed at normalising maternal plasma phenylalanine concentration.

Authors:  G N Thompson; D E Francis; D M Kirby; R Compton
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

7.  An occipito-temporal syndrome in adolescents with optimally controlled hyperphenylalaninaemia.

Authors:  H C Lou; P B Toft; J Andresen; I Mikkelsen; B Olsen; F Güttler; S Wieslander; O Henriksen
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

8.  Brain magnetic resonance imaging in children with optimally controlled hyperphenylalaninaemia.

Authors:  P B Toft; H C Lou; I Krägeloh-Mann; J Andresen; F Güttler; P Guldberg; O Henriksen
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.